203 related articles for article (PubMed ID: 36077272)
1. TRIM28 Is a Novel Regulator of CD133 Expression Associated with Cancer Stem Cell Phenotype.
Kim YS; Potashnikova DM; Gisina AM; Kholodenko IV; Kopylov AT; Tikhonova OV; Kurbatov LK; Saidova AA; Tvorogova AV; Kholodenko RV; Belousov PV; Vorobjev IA; Zgoda VG; Yarygin KN; Lupatov AY
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077272
[TBL] [Abstract][Full Text] [Related]
2. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
4. Proliferative Activity of Colorectal Cancer Cells with Different Levels of CD133 Expression.
Gisina AM; Kim YS; Potashnikova DM; Tvorogova AV; Yarygin KN; Lupatov AY
Bull Exp Biol Med; 2019 Aug; 167(4):541-545. PubMed ID: 31502129
[TBL] [Abstract][Full Text] [Related]
5. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
6. CEACAM5 overexpression is a reliable characteristic of CD133-positive colorectal cancer stem cells.
Gisina A; Novikova S; Kim Y; Sidorov D; Bykasov S; Volchenko N; Kaprin A; Zgoda V; Yarygin K; Lupatov A
Cancer Biomark; 2021; 32(1):85-98. PubMed ID: 34092615
[TBL] [Abstract][Full Text] [Related]
7. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line.
de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL
APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563
[TBL] [Abstract][Full Text] [Related]
8. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
[TBL] [Abstract][Full Text] [Related]
10. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
12. Notch1 directly induced CD133 expression in human diffuse type gastric cancers.
Konishi H; Asano N; Imatani A; Kimura O; Kondo Y; Jin X; Kanno T; Hatta W; Ara N; Asanuma K; Koike T; Shimosegawa T
Oncotarget; 2016 Aug; 7(35):56598-56607. PubMed ID: 27489358
[TBL] [Abstract][Full Text] [Related]
13. Incomplete radiofrequency ablation promotes the development of CD133
Yuan CW; Wang ZC; Liu K; Liu DJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):416-422. PubMed ID: 30262419
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling Warburg effect and stemness in CD133
Koka P; Mundre RS; Rangarajan R; Chandramohan Y; Subramanian RK; Dhanasekaran A
Mol Biol Rep; 2018 Dec; 45(6):1653-1662. PubMed ID: 30128626
[TBL] [Abstract][Full Text] [Related]
15. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
[TBL] [Abstract][Full Text] [Related]
16. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133
Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C
Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199
[TBL] [Abstract][Full Text] [Related]
17. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
[TBL] [Abstract][Full Text] [Related]
18. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
[TBL] [Abstract][Full Text] [Related]
19. Exosomes from CD133
Zhao H; Chen S; Fu Q
J Cell Biochem; 2020 Jun; 121(5-6):3286-3297. PubMed ID: 31960989
[TBL] [Abstract][Full Text] [Related]
20. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]